GSK and CureVac to develop vaccine shot for emerging virus. | UK |

Be the First to Comment Read

GSK and CureVac to develop vaccine shot for emerging virus. | UK |

Two major pharma companies, GlaxoSmithKline and CureVac inked a new deal worth EUR 150 mn (GBP 132 mn) to develop next-generation covid-19 vaccines against newer strains of the virus.

* Zap-Map signs up ESB Energy to its Zap-Pay service The UK's leading electric vehicle (EV) mapping service Zap-Map signed ESB Energy as the latest charge point operator to join its Zap-Pay service.

* Lloyds’ makes payment of £17,000 to CMA for PPI customers refund 8,800 people were sent incorrect information in annual reminders to mortgage PPI customers.

Disclaimer

Speak your Mind